Abstract:Background The transcription factor Spi-1 proto-oncogene (SPI1, also known as PU.1) is a key regulator of signal communication in the immune system and is essential for the development of myeloid cells and lymphocytes. However, the potential role of SPI1 in gastric cancer (GC) and the correlations between SPI1 and immune infiltration remain unclear. Methods In the present study, multiple databases including ONCOMINE, TIMER, Kaplan–Meier Plotter, and The Cancer Genome Atlas were used to explore the expression levels and prognostic value of SPI1 in GC. cBioPortal was used to explore the possible reasons for the increased expression of SPI1 in GC. The correlations between SPI1 expression and tumor-infiltrating immune cells (TICs) were analyzed using CIBERSORT and TIMER. Gene set enrichment analysis was used to determine the biological function of SPI1 in the development of GC. In addition, a risk signature based on SPI1-related immunomodulators was constructed to accurately evaluate the prognosis of patients with GC. The upregulation of SPI1 expression in GC was further confirmed through immunohistochemistry, western blotting, and real-time quantitative PCR (RT-qPCR) assay. Results The expression of SPI1 was increased significantly in GC according to multiple databases, and high expression of SPI1 was related to poor prognosis and progression of GC. The main factor influencing the high expression of SPI1 mRNA in GC may be diploidy, not DNA methylation. Moreover, immunohistochemistry, western blotting, and RT-qPCR assays also confirmed the upregulated expression of SPI1 in GC. CIBERSORT analysis revealed that SPI1 expression was correlated with seven types of TICs (naive B cells, resting memory CD4 T cells, activated memory CD4 T cells, activated natural killer cells, resting natural killer cells, M2 macrophages, and resting dendritic cells). Gene set enrichment analysis indicated that SPI1 might be related to immune activation in GC and participate in cell cycle regulation. In addition, based on SPI1-related immunomodulators, we developed multiple-gene risk prediction signatures and constructed a nomogram that can independently predict the clinical outcome of GC. Conclusion The results of the present study suggest that SPI1 has a critical role in determining the prognosis of GC patients and may be a potential immunotherapeutic target.

Transcription Factor Sp1 Expression in Gastric Cancer and Its Relationship to Long-Term Prognosis

[Transcription Factor Sp1 Expression in Gastric Cancer and Its Prognostic Value].

[Expression of Transcription Factor Sp1 in Human Gastric Cancer Tissue and Its Correlation with Prognosis].

Research Progress on Relationship Between Transcription Factor Sp1 and Tumor

Altered Expression of Transcription Factor Sp1 Critically Impacts the Angiogenic Phenotype of Human Gastric Cancer

196P Expression of Musashi-1 Protein and Its Implications in Progression and Prognosis of Gastric Cancer

Expression of Transcription Factor Sp1 in Human Pancreatic Ductal Carcinoma and Its Relationship with Prognosis

SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis.

Correlation of transcription factor Sp1 expression with clinical and pathological characteristics and prognosis of hepatocellular carcinoma

High Co-Expression of Sp1 and HER-2 is Correlated with Poor Prognosis of Gastric Cancer Patients

Sp1 Is Upregulated In Human Glioma, Promotes Mmp-2-Mediated Cell Invasion And Predicts Poor Clinical Outcome

Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer

Elevated THBS2, COL1A2, and SPP1 Expression Levels as Predictors of Gastric Cancer Prognosis.

[Expression of metastasis associated 1 family member 2 (MTA2) in gastric cancer and its relationship with transcription factor Sp1].

Reduced Selenium-Binding Protein 1 is Associated with Poor Survival Rate in Gastric Carcinoma.

Sphingosine Kinase 1 is Associated with Gastric Cancer Progression and Poor Survival of Patients

A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer

[Association of T helper cell 1 cytokines expressions with prognosis of gastric cancer patients].

[Relationship Between Sphingosine Kinase 1 Expression and Tumor Invasion, Metastasis and Prognosis in Gastric Cancer].

Decreased Expression of AZGP1 is Associated with Poor Prognosis in Primary Gastric Cancer

Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment